COVID-19 and Vaccination in Children and Adolescents: From Bench to Exam Room - Symposium Supported by PfizerSession Description:Join us as we explore the benefits and risks of vaccination in children and adolescents. This symposium includes expert discussion on:•Burden of SARS-CoV-2•Clinical Trial Data for BNT162b2•Benefits and risks of vaccinating

The introduction and use of acellular pertussis combination vaccines – real-world experiences - Symposium Supported by SanofiSession Description: Young infants are especially vulnerable to infections, with potentially serious morbidity and mortality throughout the world. Respiratory infections caused by Bordetella pertussis remain prevalent worldwide, with an estimated over 24 million pertussis cases per year. Vaccines to protect against pertussis have been available for several decades. Continued developments have been seen over time with the introduction of combined formulations and a switch from whole-cell to acellular vaccines. Today, combined acellular vaccines are commonly used in clinical practice, showing fewer adverse events than their whole-cell counterparts and combined formulations offering logistical benefits. Despite availability of these vaccines to provide the opportunity to protect vulnerable populations, vaccine coverage rates remain suboptimal and actually dropped in recent years in several countries. This problem has been further exacerbated by the COVID-19 pandemic. The expert panel will describe country-specific learnings and experiences associated with the introduction and use of acellular pertussis combination vaccines and will present the implications on real-world clinical practice. There will be a discussion of important learnings relevant to all attendees, with the goal of achieving equitable access to vaccines worldwide.